Drexel joins with Roche's Spark Therapeutics to build $575 million facility in Philly

Retrieved on: 2021-12-17 15:13:29

Tags for this article:

Click the tags to see associated articles and topics

Drexel joins with Roche's Spark Therapeutics to build $575 million facility in Philly. View article details on hiswai:

Excerpt

Acquired by Swiss biotech giant Roche for $4.8 billion, Spark Therapeutics will manufacture gene therapy treatments at the facility, ...

Article found on: www.inquirer.com